Get startedLog in
    Picture of Swedish Orphan Biovitrum AB (publ) logo

    SOBI — Swedish Orphan Biovitrum AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    All News

    Brief: Swedish Orphan Biovitrum Proposes No Dividend For 2025

    Picture of Swedish Orphan Biovitrum AB (publ) logoSwedish Orphan Biovitrum AB (publ)
    05/02/2026 07:11
    Feb 5 (Reuters) - Swedish Orphan Biovitrum AB (publ) SOBIV.ST:

Q4 REVENUE SEK 7,821 MILLION VERSUS. IBES ESTIMATE SEK 8,037 MILLION

Q4 ADJUSTED EPS SEK 5.39

Q4 ADJUSTED FREE CASH FLOW SEK 2,981 MILLION

Q4 TOTAL REVENUE INCREASED 5 PER CENT, 16 PER CENT AT CER1, TO SEK 7,821 M (7,436)

PROPOSES THAT NO DIVIDEND IS PAID FOR THE 2025 FINANCIAL YEAR

OUTLOOK 2026:  REVENUE IS ANTICIPATED TO GROW AT LOW DOUBLE-DIGIT PERCENTAGE AT CER

OUTLOOK 2026: THE ADJUSTED EBITA MARGIN IS ANTICIPATED TO BE IN THE MID 30S PERCENTAGE OF REVENUE

Source text: ID:nWkr348yjP

Further company coverage: SOBIV.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Swedish Orphan Biovitrum AB (publ)

    See all news